Amgen Inc. (AMGN) Presents at Morgan Stanley 23rd Annual Global Healthcare Conference

Follow Play Earnings CallPlay Earnings Call Amgen Inc. (NASDAQ:AMGN) Morgan Stanley 23rd Annual Global Healthcare Conference…

Amgen Reports Preliminary Phase 3 Trial Results For Rocatinlimab In Moderate-to-Severe AD

(RTTNews) – Amgen (AMGN) and Kyowa Kirin Co., Ltd. announced preliminary top-line results from the ASCEND…

Amgen Plans $600M Innovation Center at Thousand Oaks Headquarters

Pharmaceutical giant Amgen plans to invest more than $600 million in a new center for science and innovation…

Amgen: Great Starting Yield For This Wealth Compounder (NASDAQ:AMGN)

This article was written by Follow I am Gen Alpha. I have more than 14 years…

Amgen: A Defensive Biotech With Yield And Optionality (NASDAQ:AMGN)

This article was written by Follow I am a stock analyst with over 20 years of…

Amgen Inc. (AMGN) BofA Securities 2025 Healthcare Conference (Transcript)

Amgen Inc. (NASDAQ:AMGN) BofA Securities 2025 Healthcare Conference Call May 14, 2025 12:20 PM ET Company…